Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America

2 years ago

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

Klara® Transforms Patient Intake Processes for athenahealth Users, Helping Save Time and Enhancing Healthcare Efficiency

2 years ago

BOCA RATON, Fla.--(BUSINESS WIRE)--Klara®, a leader in patient communication and engagement, is proud to introduce its patient intake product, designed…

Surescripts Launches Third Season of Its Award-Winning Podcast There’s A Better Way

2 years ago

ARLINGTON, Va.--(BUSINESS WIRE)--#healthIT--Surescripts®, the nation’s leading health information network, launched the third season of its award-winning podcast, There’s a Better…

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

2 years ago

New Appointments Underscore Commitment to Driving Innovation and Industry-Leading GrowthLAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer,…

CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and Transplantation

2 years ago

Companies aim to enhance organ donation efforts by pairing cutting-edge telediagnostic solutions with innovative marketing strategies LOS ANGELES, CA and…

Monogram Provides Regulatory Update Following Meeting with FDA

2 years ago

510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 /…

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

2 years ago

Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery  Treatment of rheumatoid…

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million

2 years ago

Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from…

SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level

2 years ago

- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and…

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

2 years ago

The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearanceMALVERN, Pa., May…